How I Treat
-
How Did We Successfully Treat Advanced Diffuse Large B-cell Lymphoma with Sequential Multi-target CART Therapy?
Authors: Yuehui LIN, Shuangyou LIU, Chunrong TONGWe have successfully treated a lady with advanced diffuse large B-cell lymphoma (DLBCL) by sequentially murinized CD19-CART, humanized CD20-CART and …
-
Professor Yonghong ZHANG: Autologous Chimeric Antigen Receptor T Cell (CAR-T) Therapy Successfully Treated One Case of Refractory Burkitt's Lymphoma
Editor's note: Burkitt's lymphoma (BL) is a highly invasive B-cell lymphoma that is highly prevalent in children, and it is the most common pathological type of non-Hodgkin's lymphoma in…
-
Case Sharing │ Autologous CAR-T Cell Immunotherapy for Extramedullary Relapse of B-cell Acute Lymphoblastic Leukemia/Lymphoma
Case IntroductionThe child, female, 7 years old, was admitted to our hospital due to B-cell acute lymphoblastic leukemia/lymphoma (medium risk, CR1) and central nervous system leukemia, medium-risk …
-
Case sharing | Application of trametinib in the prevention of relapsed T-cell acute lymphoblastic leukemia after salvage hematopoietic stem cell transplantation
Case summaryThe child Long XX, male, 9 years old, was diagnosed with relapsed T-cell acute lymphoblastic leukemia (T-ALL) complicated with multiple extramedullary leukemia (testes and central nervou…
-
How we successfully treated a patient with refractory relapsed multiple myeloma complicated with TP53 gene variation and central nervous system infiltration using autologous BCMA-CART
How we successfully treated a patient with refractory relapsed multiple myeloma complicated with TP53 gene variation and central nervous system infiltration using autologous BCMA-CARTMultiple myelom…
